The benefits of PCSK9 inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis
Abstract. Background. Proprotein convertase subtilisin/kexin 9 (PSCK9) inhibitors have been beneficial for many patients with hyperlipidemia. The objective of this study was to investigate the benefit of PSCK9 inhibitors in patients with acute coronary syndrome (ACS). Methods. We systematically sear...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Wolters Kluwer Health/LWW
2024-03-01
|
| Σειρά: | Emergency and Critical Care Medicine |
| Διαθέσιμο Online: | http://journals.lww.com/10.1097/EC9.0000000000000108 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|